Adalimumab-Associated Hemorrhagic Pericarditis

Am J Ther. 2020 Nov/Dec;27(6):e630-e632. doi: 10.1097/MJT.0000000000001019.

Authors

Rohit Vyas¹, Firas A Adeel¹, Taha Sheikh¹, Mubbasher Syed^{1

2}, Nezam Altorok^{1

3}

Affiliations

¹ Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH.
² Division of Cardiology, Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH.
³ Division of Rheumatology and Immunology, Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH.

PMID: 31241494
DOI: 10.1097/MJT.0000000000001019

No abstract available

MeSH terms

Adalimumab / adverse effects
Hemorrhage / chemically induced
Humans
Pericarditis* / chemically induced

Substances

Adalimumab